Policy / executive actionupcoming

MAHA peptide-access framework — expected HHS rollout

Thursday, October 15, 2026 · Federal agency

The HHS / Make America Healthy Again administration is expected to publish a peptide-access framework in Q4 2026 — outlining 'Ethical Channel' compounding pathways and signaling potential FDA Category reclassification for non-injectable peptides.

Peptides affected

  • BPC-157
  • Sermorelin
  • Cerebrolysin
  • GHK-Cu
  • Selank

Sources & further reading

Regulatory event entry on peptide regulatory calendar. Event details may change as the agency publishes updates — verify against the primary source above before acting on the timeline.